Corbett Road Capital Management, LLC Edwards Lifesciences Corp Transaction History

Corbett Road Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$78.68 - $90.67 $276,166 - $318,251	-3,510 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$71.69 - $91.23 $22,295 - $28,372	-311 Reduced 8.14%	3,510 $320,000
Q3 2020 Oct 29, 2020	BUY	$67.19 - $87.44 $256,732 - $334,108	3,821 New	3,821 $305,000
Q1 2020 Apr 22, 2020	SELL	$52.41 - $81.0 $52,252 - $80,757	-997 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$71.7 - $82.09 $71,484 - $81,843	997 New	997 $233,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Corbett Road Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Corbett Road Capital Management, LLC with notifications on news.